Actinium Pharmaceuticals Clinical/Near-Clinical Trials Status
Actinium Pharmaceuticals Preclinical Development Status
1 HSCT stands for Hematopoetic Stem Cell Transplantation;
2 Properties of actinium 225 are uniquely suited for antiangiogenesis and API is considering options for further development in that area.